文献
J-GLOBAL ID:201802230797836226
整理番号:18A0269859
局所進行性または転移性すい臓癌(ViP)におけるバンデタニブ+ゲムシタビン対プラセボプラスゲムシタビン:前向き,無作為化,二重盲検,多施設第2相試験【Powered by NICT】
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
著者 (26件):
Middleton Gary
(University of Birmingham, Edgbaston, Birmingham, UK)
,
Palmer Daniel H
(Liverpool Cancer Research UK Cancer Trials Unit and LCTU-GCPLabs, University of Liverpool, Liverpool, UK)
,
Palmer Daniel H
(Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK)
,
Greenhalf William
(Liverpool Cancer Research UK Cancer Trials Unit and LCTU-GCPLabs, University of Liverpool, Liverpool, UK)
,
Ghaneh Paula
(Liverpool Cancer Research UK Cancer Trials Unit and LCTU-GCPLabs, University of Liverpool, Liverpool, UK)
,
Jackson Richard
(Liverpool Cancer Research UK Cancer Trials Unit and LCTU-GCPLabs, University of Liverpool, Liverpool, UK)
,
Cox Trevor
(Liverpool Cancer Research UK Cancer Trials Unit and LCTU-GCPLabs, University of Liverpool, Liverpool, UK)
,
Evans Anthony
(Liverpool Cancer Research UK Cancer Trials Unit and LCTU-GCPLabs, University of Liverpool, Liverpool, UK)
,
Shaw Victoria E
(Liverpool Cancer Research UK Cancer Trials Unit and LCTU-GCPLabs, University of Liverpool, Liverpool, UK)
,
Wadsley Jonathan
(Weston Park Hospital, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK)
,
Valle Juan W
(Division of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UK)
,
Valle Juan W
(Christie NHS Foundation Trust, Manchester, UK)
,
Propper David
(Centre for Cancer and Inflammation, Barts Cancer Institute, London, UK)
,
Wasan Harpreet
(Hammersmith Hospital, London, UK)
,
Falk Stephen
(Bristol Haematology and Oncology Centre, University Hospital Bristol NHS Foundation Trust, Bristol, UK)
,
Cunningham David
(Royal Marsden, Royal Marsden NHS Foundation Trust, London, UK)
,
Coxon Fareeda
(Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle upon Tyne, UK)
,
Ross Paul
(Guy’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, UK)
,
Madhusudan Srinivasan
(Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK)
,
Wadd Nick
(James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesborough, UK)
,
Corrie Pippa
(Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK)
,
Hickish Tamas
(Poole Hospital NHS Foundation Trust, Bournemouth University, Poole, UK)
,
Costello Eithne
(Liverpool Cancer Research UK Cancer Trials Unit and LCTU-GCPLabs, University of Liverpool, Liverpool, UK)
,
Campbell Fiona
(Liverpool Cancer Research UK Cancer Trials Unit and LCTU-GCPLabs, University of Liverpool, Liverpool, UK)
,
Rawcliffe Charlotte
(Liverpool Cancer Research UK Cancer Trials Unit and LCTU-GCPLabs, University of Liverpool, Liverpool, UK)
,
Neoptolemos John P
(Liverpool Cancer Research UK Cancer Trials Unit and LCTU-GCPLabs, University of Liverpool, Liverpool, UK)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
18
号:
4
ページ:
486-499
発行年:
2017年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)